Mohammad W.
- Country
- Germany
- Department
- Klinik f. Hämatologie, Onkologie, Palliativmedizin, Stammzelltransplantation
Research Overview
- Phase III Randomized, Placebo-Controlled Study of Venetoclax with Induction and Consolidation Chemotherapy in Newly Diagnosed AML or MDS-EB2 Patients
- Evaluation of Adjuvant Therapy with Capecitabine in Stage II Colon and Rectal Cancer Patients with ctDNA Positivity Post-Resection
- Phase III Randomized Trial of Iberdomide vs. Iberdomide Plus Isatuximab Post-Autologous Hematopoietic Stem-Cell Transplantation in Newly Diagnosed Multiple Myeloma
Data & Insights
Has run more than one trial at 146 of 280 partner sites.
Specializations
Hematologic Malignancies
This investigator specializes in treating various blood cancers, with particular focus on acute lymphoblastic leukemia, acute myeloid leukemia, and multiple myeloma.
- Philadelphia-Chromosome positive ALL treatment strategies
- Novel therapies for AML including venetoclax combinations
- Multiple myeloma maintenance therapy approaches
Special interest in developing treatment protocols involving targeted therapies and immunotherapeutic approaches.
Solid Tumor Oncology
The investigator focuses on innovative approaches in colon cancer treatment and management of hepatocellular carcinoma.
- Preoperative treatment strategies in resectable colon cancer
- Circulating tumor DNA-guided therapy
- Combined immunotherapy approaches in liver cancer
Expertise in developing personalized treatment strategies based on molecular markers and disease characteristics.
Myelodysplastic Syndromes
Dedicated to advancing treatment options for patients with myelodysplastic syndromes, particularly focusing on novel therapeutic approaches.
- Treatment of lower-risk MDS
- Novel erythropoiesis-stimulating strategies
- Management of MDS-related anemia
Specialized interest in developing treatments for patients who are treatment-naïve or have specific genetic profiles.
Related Investigators
Researchers in similar fields or departments
Want to know more about this investigator?
We can share extended profile information and contact details.
Is something out of date?
Tell us what needs correcting and we'll update this profile.